Back to search page

RDGR20180503001

EuroNanoMed 3/2018-phase II (full proposal) – biotech SMEs from Spain, Latvia or Lithuania sought to develop new nano-immunomedicines for Alzheimer’s disease.

Sorry, this profile is no longer available for expressions of interest, it may have expired or been withdrawn from publication - return to the search page

KEY INFORMATION

Country of origin
GREECE
Profile date
16/05/2018
Deadline
21/05/2018

PARTNERSHIP(S) SOUGHT

Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Nanotechnology & Nanoscience \ Life Sciences \ Biosciences and Health \ Environment & Protecting Man \ Drug Discovery and Drug Development \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Medical Research / BIOLOGICAL SCIENCES / Medicine, Human Health / Pharmaceutical Products / Drugs / BIOLOGICAL SCIENCES / Micro- and Nanotechnology related to Biological sciences
COMMERCIAL KEYWORDS
none...
MARKET KEYWORDS
GENETIC ENGINEERING/MOLECULAR BIOLOGY / Micro- and Nanotechnology related to Biological sciences / MEDICAL/HEALTH RELATED / Anatomy, Pathology, Immunology, Physiology / MEDICAL/HEALTH RELATED / Other Medical/Health Related / Pharmaceuticals/fine chemicals

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number RDGR20180503001